|
NGNE Neurogene Inc 1404644 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-34,488,000.00 |
| Balance Sheet |
|
Current Assets
|
$228,913,000.00 |
|
Assets
|
$244,364,000.00 |
|
Current Liabilities
|
$21,505,000.00 |
|
Liabilities
|
$27,231,000.00 |
|
Equity
|
$217,133,000.00 |
|
Shares Out
|
15830504.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-49,880,000.00 |
|
Investing Cash Flow
|
$52,344,000.00 |
| Market Analysis |
Market Cap
|
$601,400,846.96 |
|
Price
|
$37.99 |
|
BVPS
|
13.72 |
|
PB
|
2.77 |
|
EPS
|
-1.53 |
|
FCF
|
$-50,515,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:39 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:30 |
|
| Apr |
May |
Jun |
| 2026-03-24 |
-4.24 |
|
|
2026-05-12 |
-1.39 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-1.05 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.99 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NGNE documents filed with the SEC.
NGNE Filings
Clear
